MediWound (MDWD) Shares Outstanding (2013 - 2026)
MediWound (MDWD) posted quarterly Shares Outstanding (Entity) of $12.8 million for Q4 2025, up 18.92% year-over-year from $10.8 million in Q4 2024, and up 16.45% quarter-over-quarter from $11.0 million in Q3 2025.
MediWound (MDWD) Shares Outstanding (2013 - 2026) Analysis & Trends
MediWound's Shares Outstanding (Entity) history runs 13 years deep, the most recent figure standing at $12.8 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 18.92% year-over-year to $12.8 million; the TTM figure through Dec 2025 stood at $12.8 million (up 18.92% YoY), while the FY2025 annual figure was $12.8 million, up 18.92% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $12.8 million, up from $11.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $12.8 million in Q4 2025, with the low at $4734.0 in Q2 2022.
- The 5-year median for Shares Outstanding (Entity) is $8.8 million (2023), against an average of $7.1 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) tumbled 99.88% in 2022, then jumped 100738.88% in 2024.
- MediWound's Shares Outstanding (Entity) stood at $3.9 million in 2021, then rose by 28.0% to $5.0 million in 2022, then soared by 84.91% to $9.2 million in 2023, then advanced by 17.04% to $10.8 million in 2024, then rose by 18.92% to $12.8 million in 2025.
- Business Quant data shows MDWD's Shares Outstanding (Entity) at $12.8 million in Q4 2025, $11.0 million in Q3 2025, and $10.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | 12.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.38 Mn |
| Dec 31, 2025 | 11.38 Mn |
| Sep 30, 2025 | 11.02 Mn |
| Jun 30, 2025 | 10.84 Mn |
| Mar 31, 2025 | 10.80 Mn |
| Dec 31, 2024 | 9.96 Mn |
| Sep 30, 2024 | 10.51 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Mar 31, 2024 | 9.23 Mn |
| Dec 31, 2023 | 9.01 Mn |
| Sep 30, 2023 | 9.22 Mn |
| Jun 30, 2023 | 9,209.00 |
| Mar 31, 2023 | 8.39 Mn |
| Dec 31, 2022 | 4.99 Mn |
| Sep 30, 2022 | 4.78 Mn |
| Jun 30, 2022 | 4,734.00 |
| Mar 31, 2022 | 4.10 Mn |
| Dec 31, 2021 | 3.89 Mn |
| Sep 30, 2021 | 3.89 Mn |
| Jun 30, 2021 | 3.89 Mn |